The term “idiotypic specificity” was first proposed to designate a unique individual antigenic determinant of immunoglobulins which was not present on antibodies of the s [...]

Adeno-­‐associated virus (AAV) is a leading candidate as a gene therapy vector, but as with other vectors, one of the limitations is a host-neutralizing immune response.